logo
Sign in

Akouos

Boston, MA · Founded 2016 · Medtech · Acquired

Cochlear drug delivery system that infuses therapeutic molecules directly to sensory cells via the round window membrane

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Boston, MA
Founded
2016
Latest Form D
$105M, Mar 2020
Total capital
$138M
Federal grants
$447K
2 awards · 2017
Rank in peer group#431 of 542
Private capital raised
$138M
3 Form D · last Mar 2020
80 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
15
25 pending · first 2022
Rank in peer group#12 of 542

Capital timeline

2017201820192020FEDERAL ↑EQUITY ↓Cumulative $138M$224K$224K1st Form D$7.6M2nd Form D$25.1M3rd Form D$105M
2017201820192020FEDERAL ↑EQUITY ↓Cumulative $138M$224K$224K1st Form D$7.6M2nd Form D$25.1M3rd Form D$105M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$105M
  • Private capital raisedForm D · SEC · 2nd filing$25.1M
  • Private capital raisedForm D · SEC · 1st filing$7.6M
  • Federal grantHealth and Human S · Phase I · Minimally Invasive Delivery System for Treatment of Inner Ear Disorders$224K
  • Federal grantHealth and Human S · Phase I · Minimally Invasive Delivery System for Treatment of Inner Ear Disorders$224K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

7months

from Akouos’s first federal award to its first private round.

First federal award · Apr 2017
Health and Human S · $224K
First Form D · Nov 2017
$7.6M · 1st Form D
Awards before first raise
2 awards

An association in public records, not a cause or a prediction.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#12 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Emmanuel SimonsResearcherExecutive Officer, DirectorLinked by $224K in grants as PI
  • Aninda KatragaddaExecutive OfficerNamed in SEC Form D filings
  • Arthur TzianabosDirectorNamed in SEC Form D filings
  • Chris SmithDirectorNamed in SEC Form D filings
  • Ed MathersDirectorNamed in SEC Form D filings
  • Heather PrestonDirectorNamed in SEC Form D filings
Show all 9 people
  • Karoline ShairExecutive OfficerNamed in SEC Form D filings
  • Kush ParmarDirectorNamed in SEC Form D filings
  • Vicki SatoDirectorNamed in SEC Form D filings

What it has protected

USPTO · 15 granted of 40
Show all 40 patent records

Related companies, and why

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .